Stockreport

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows [Yahoo! Financ...

Akoya BioSciences, Inc.  (AKYA) 
PDF Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company ® , and Shanghai KR Pharmtech, a leading company providing molecular diagnostic solutions in China, have jo [Read more]